We are live on ! Find out more
NPA

Nichols & Pratt Advisers Portfolio holdings

AUM $1.55B
1-Year Est. Return 14.55%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+14.55%
3 Year Est. Return
+54.54%
5 Year Est. Return
+81.09%
10 Year Est. Return
+238.91%
AUM
$1.21B
AUM Growth
+$25.7M
Cap. Flow
-$5.71M
Cap. Flow %
-0.47%
Top 10 Hldgs %
45.39%
Holding
108
New
3
Increased
31
Reduced
48
Closed
3

Top Buys

Rank Stock Value
1
ALC icon
Alcon
ALC
+$5.05M
2
T icon
AT&T
T
+$1.27M
3
DIS icon
Walt Disney
DIS
+$706K
4
CB icon
Chubb
CB
+$561K
5
KMI icon
Kinder Morgan
KMI
+$554K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$5.2M
2
EMR icon
Emerson Electric
EMR
+$1.37M
3
SYY icon
Sysco
SYY
+$1.31M
4
CL icon
Colgate-Palmolive
CL
+$1.1M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.06M

Sector Composition

Rank Sector Weight
1 Technology 22.28%
2 Healthcare 22.23%
3 Consumer Staples 17%
4 Industrials 10.44%
5 Financials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UL icon
26
Unilever
UL
$137B
$15.7M 1.29%
224,468
-1,399
-0.6% -$95K
EXPD icon
27
Expeditors International
EXPD
$22B
$15.2M 1.25%
200,828
-476
-0.2% -$35.9K
LIN icon
28
Linde
LIN
$221B
$14.9M 1.23%
74,436
-2,626
-3% -$491K
SO icon
29
Southern Company
SO
$109B
$13.7M 1.13%
248,667
-445
-0.2% -$23.8K
SYK icon
30
Stryker
SYK
$125B
$13.5M 1.11%
65,695
-260
-0.4% -$49.7K
NVO
31
Novo Nordisk
NVO
$208B
$12.8M 1.05%
500,592
+8,006
+2% +$198K
STT icon
32
State Street
STT
$50.6B
$12.8M 1.05%
227,926
+466
+0.2% +$29K
CVS icon
33
CVS Health
CVS
$133B
$12.1M 1%
222,646
+7,404
+3% +$399K
ACN icon
34
Accenture
ACN
$102B
$11.7M 0.96%
63,338
+2,630
+4% +$472K
MDT icon
35
Medtronic
MDT
$109B
$11.5M 0.95%
118,259
+4,157
+4% +$380K
INTU icon
36
Intuit
INTU
$86.5B
$11.4M 0.93%
43,423
-775
-2% -$197K
MMM icon
37
3M
MMM
$90.9B
$10.8M 0.89%
74,574
+1,947
+3% +$300K
WBA
38
DELISTED
Walgreens Boots Alliance
WBA
$10.6M 0.87%
193,153
-1,702
-0.9% -$90.5K
SBUX icon
39
Starbucks
SBUX
$120B
$10.3M 0.85%
122,355
-85
-0.1% -$6.67K
AMZN icon
40
Amazon
AMZN
$2.92T
$9.25M 0.76%
97,640
+2,280
+2% +$212K
QCOM icon
41
Qualcomm
QCOM
$155B
$9.25M 0.76%
121,522
-13,658
-10% -$1M
ECL icon
42
Ecolab
ECL
$78.1B
$7.93M 0.65%
40,216
-150
-0.4% -$27.9K
SLB icon
43
SLB Ltd
SLB
$73.6B
$7.7M 0.63%
193,783
-7,310
-4% -$295K
SYY icon
44
Sysco
SYY
$40.8B
$6.95M 0.57%
98,266
-18,450
-16% -$1.31M
GILD icon
45
Gilead Sciences
GILD
$162B
$5.73M 0.47%
84,733
-6,707
-7% -$441K
APD icon
46
Air Products & Chemicals
APD
$65.7B
$5.4M 0.44%
23,780
+2,395
+11% +$496K
ALC icon
47
Alcon
ALC
$33.6B
$5.34M 0.44%
+86,064
New +$5.05M
ABT icon
48
Abbott
ABT
$183B
$5.08M 0.42%
60,341
-264
-0.4% -$20.8K
GE icon
49
GE Aerospace
GE
$374B
$4M 0.33%
76,457
-21,404
-22% -$1.05M
PFE icon
50
Pfizer
PFE
$143B
$3.58M 0.29%
87,036
+2,240
+3% +$88.9K

Similar funds

Nichols & Pratt Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, Nichols & Pratt Advisers held 108 positions worth $1.21B, up 2.2% from $1.19B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Nichols & Pratt Advisers's Q2 2019 filing shows 3 new, 31 increased, 48 reduced and 3 closed positions. Its largest new stake was Alcon: 86,064 shares worth $5.34M. The largest sale was Novartis, an estimated $5.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Nichols & Pratt Advisers's largest Q2 2019 buy was Alcon: 86,064 shares worth $5.34M.
  • Nichols & Pratt Advisers added most to AT&T in Q2 2019, an estimated $1.27M increase.
  • Nichols & Pratt Advisers's biggest Q2 2019 reduction was Novartis, cutting an estimated $5.2M.
  • Nichols & Pratt Advisers fully exited DuPont de Nemours in Q2 2019, selling an estimated $427K.
  • Nichols & Pratt Advisers's ten largest holdings make up 45% of its $1.21B portfolio in Q2 2019.
  • Nichols & Pratt Advisers opened 3 new positions and closed 3 in Q2 2019.
  • Nichols & Pratt Advisers's portfolio value rose 2.2% quarter-over-quarter to $1.21B.

Based on Nichols & Pratt Advisers's 13F filing for Q2 2019, filed 5 Aug 2019.